Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biomarkers as intermediate end points in chemoprevention trials.

× No keyword cloud information.

18 in total

Review 1. Biomarkers as surrogates for cancer development.

Authors: E Hawk; J L Viner; J A Lawrence
Journal: Curr Oncol Rep Date: 2000-05 Impact factor: 5.075

Review 2. Markers for nutrition studies: review of criteria for the evaluation of markers.

Authors: Jan de Vries; Jean-Michel Antoine; Tomasz Burzykowski; Alessandro Chiodini; Mike Gibney; Gunter Kuhnle; Agnès Méheust; Loek Pijls; Ian Rowland
Journal: Eur J Nutr Date: 2013-08-17 Impact factor: 5.614

3. n-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa.

Authors: Y C Huang; J M Jessup; R A Forse; S Flickner; D Pleskow; H T Anastopoulos; V Ritter; G L Blackburn
Journal: Lipids Date: 1996-03 Impact factor: 1.880

Review 4. Phase II cancer prevention clinical trials.

Authors: Eva Szabo
Journal: Semin Oncol Date: 2010-08 Impact factor: 4.929

5. Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients.

Authors: Cheryl Clark; Shivang Shah; Lilantha Herman-Ferdinandez; Oleksandr Ekshyyan; Fleurette Abreo; Xiaohua Rong; Jerry McLarty; Aubrey Lurie; Edward J Milligan; Cherie-Ann O Nathan
Journal: Laryngoscope Date: 2010-06 Impact factor: 3.325

6. Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway.

Authors: Pandurangan Ashokkumar; Ganapasam Sudhandiran
Journal: Invest New Drugs Date: 2009-12-15 Impact factor: 3.850

Review 7. Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors: V A Papadimitrakopoulou; D M Shin; W K Hong
Journal: Cancer Metastasis Rev Date: 1996-03 Impact factor: 9.264

Review 8. Risks and benefits of retinoids in the chemoprevention of cancer.

Authors: G de Palo; F Formelli
Journal: Drug Saf Date: 1995-10 Impact factor: 5.606

9. Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Authors: C J Fabian; C Zalles; S Kamel; B F Kimler; R McKittrick; A S Tranin; S Zeiger; W P Moore; R S Hassanein; C Simon
Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872

Review 10. Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors: Eva Szabo; Jenny T Mao; Stephen Lam; Mary E Reid; Robert L Keith
Journal: Chest Date: 2013-05 Impact factor: 9.410